The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population.
OBJECTIVE:The aim of the study was to assess the effectiveness of disease-modifying therapies (DMTs) in relapsing-remitting multiple sclerosis (RRMS) patients treated in MS centres in Poland. METHODS:Demographic and clinical data of all Polish RRMS patients receiving DMTs were prospectively collecte...
Main Authors: | Katarzyna Kapica-Topczewska, Joanna Tarasiuk, Francois Collin, Waldemar Brola, Monika Chorąży, Agata Czarnowska, Mirosław Kwaśniewski, Halina Bartosik-Psujek, Monika Adamczyk-Sowa, Jan Kochanowicz, Alina Kułakowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223863 |
Similar Items
-
Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
by: Katarzyna Kapica-Topczewska, et al.
Published: (2021-02-01) -
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
by: Brandi L. Vollmer, et al.
Published: (2020-09-01) -
Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate
by: Justin M. Honce, et al.
Published: (2020-09-01) -
IMMUNOLOGICAL PRECONDITIONS OF CONVERSION FROM NATALIZUMAB TO FINGOLIMOD
by: E. V. Popova, et al.
Published: (2017-12-01) -
Month of birth and level of insolation as risk factors for multiple sclerosis in Poland.
by: Paweł Dobrakowski, et al.
Published: (2017-01-01)